Remove Blogging Remove Pricing Remove Report Remove Technical Review
article thumbnail

Netflix Redux: Is It Ever OK to Fire Your Customers?

Both Sides of the Table

The big price increase : 5 out of 5 stars. The remainder of this article will deal with this decision but it comes down to the different economics of DVD rentals due to “ the first sale doctrine ” which gives Netflix a complete library of films and the fact that the first-sale doctrine doesn’t apply to digital downloads.

Netflix 287
article thumbnail

What Do Boards Actually Do?

Both Sides of the Table

I read commentary or Twitter or blogs and realize that there are also strongly held convictions that there are these evil VCs who do terrible things to mostly altruistic founders. But unlike the popular press reporting of this conflict — 80% of the time it is founder-to-founder conflict and not investor-to-founder conflict.

Startup 217
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

One Man’s Signal is Another Man’s Noise

Both Sides of the Table

It’s apropos because there is so much noise these days with email, Twitter, Facebook, blogs, web shows, etc. I was thinking back to a few previous “insider baseball&# blog debates that raged for several weeks: AngelGate (aka Bin38 secret cabal), convertible debt vs. equity, bubble vs. not, and now the AngelList discussion.

Email 287
article thumbnail

Bio Roundup: Cancer Wishes and Shopping Lists, Allergan Pricing & More

Xconomy

The full report is here ; a summary is here.). Xconomy reached Tyler Jacks, the co-chair of the panel and director of the Koch Institute for Integrative Cancer Research at MIT, to ask about the report. Investors knocked about 30 percent off Dynavax’s share price last Friday, with only a modest recovery this week.

Pricing 40
article thumbnail

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

Xconomy

military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. —The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology. PRICE FIGHTS.

article thumbnail

Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More

Xconomy

Drug company stocks got a boost with the defeat of Hillary Clinton, a vocal critic of drug prices. Will he take a softer stance on drug prices? But her near doubling of Trump (62 to 33 percent) didn’t translate into support for drug price controls. Now, the U.S. healthcare sector will try to figure out what it all means.

Patents 87
article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. — MIT Technology Review reported this week that a graduate student in the lab of Feng Zhang, Broad Institute gene-editing star, had accused the Broad of misleading the U.S. .